Should Medical Devices Stock Neuroone Medical Technologies Corp (NMTC) Be in Your Portfolio Monday?

The 46 rating InvestorsObserver gives to Neuroone Medical Technologies Corp (NMTC) stock puts it near the middle of the Medical Devices industry. In addition to scoring higher than 62 percent of stocks in the Medical Devices industry, NMTC’s 46 overall rating means the stock scores better than 46 percent of all stocks.

NMTC has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on NMTC!

See Full NMTC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 46 means the stock is more attractive than 46 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Neuroone Medical Technologies Corp Stock Today?

Neuroone Medical Technologies Corp (NMTC) stock has risen 10.59% while the S&P 500 is down -0.21% as of 10:11 AM on Monday, Mar 25. NMTC has risen $0.13 from the previous closing price of $1.18 on volume of 165,429 shares. Over the past year the S&P 500 has risen 31.32% while NMTC is down -19.14%. NMTC lost -$0.69 per share the over the last 12 months. Click Here to get the full Stock Report for Neuroone Medical Technologies Corp stock.